spot_imgspot_imgspot_img

White House Gated GPT-5.6 for 12 Days Before Release

TRENDSPOTTING David Miller
White House gated GPT-5.6 for 12 days before release—forcing OpenAI into a government-vetted launch and setting a de facto preclearance precedent for frontier AI.

Musk v. OpenAI: Restructuring Reshapes Landmark Mission Lawsuit

TRENDSPOTTING Anya Sharma
Musk v. OpenAI: How the PBC restructuring is reshaping the landmark mission lawsuit and testing if a founding mission can survive commercial scaling.

GitHub Copilot’s Token-Based Billing Shift Sparks Developer Backlash

TRENDSPOTTING Anya Sharma
GitHub Copilot's token-based billing shift sparks developer backlash as flat-rate pricing ends. See why coders are furious and what it means for AI tool costs.

INSIDERS

JOIN THE AI REVOLUTION

Stay on top and never miss important AI news. Sign up to our newsletter.

Subscribe Now

Top 5 This Week

Family Offices Pour $68B Into AI as Private Wealth Bets Earlier

TRENDSPOTTING Anya Sharma
Family offices poured $68.3B into AI in Q3 2026 alone—discover how private wealth is betting earlier on pre-IPO AI and what concentration risk means for investors.

Family Offices Pour $68B Into AI as Private Wealth Bets Earlier

TRENDSPOTTING
Family offices poured $68.3B into AI in Q3 2026 alone—discover how private wealth is betting earlier on pre-IPO AI and what concentration risk means for investors.

AI Data Center Natural Gas: The Six Hidden Risks Nobody Prices In

DEEP DIVE
AI data center natural gas hides six unpriced risks—emissions lock-in, ratepayer costs, and stranded assets. Discover who really pays for the AI power boom.

OpenAI Taps Greptile to Chase Bugs Past the Pull Request

IN ACTION
OpenAI taps Greptile's TREX, powered by GPT-6 Astra, to catch runtime bugs that pass CI and hit production. See how AI code review is shifting.

Cognichip’s $60M Bet: Physics-Informed AI in a Crowded Chip Design Race

FUTURE FRONTIERS
Cognichip raises $60M to scale physics-informed AI chip design with ACI®—delivering manufacturable silicon and slashing design timelines up to 10x.

When a Dog’s Cancer Went Viral: The Founder-Patient Era Arrives With a $4M Bet

IN ACTION
AI-designed dog cancer vaccine goes viral, raises $4M, then fails—learn why the founder-patient era is reshaping biotech despite zero FDA approvals.

OpenAI’s Own Report Concedes AI Science’s Real Bottleneck: Verification

FUTURE FRONTIERS
OpenAI's own report reveals AI science's real bottleneck is verification, not code generation—why human trust now limits AI discovery.

Don't Miss

spot_imgspot_imgspot_imgspot_img

IN ACTION

AI Data Center Natural Gas: The Six Hidden Risks Nobody Prices In

Grace Lee
AI data center natural gas hides six unpriced risks—emissions lock-in, ratepayer costs, and stranded assets. Discover who really pays for the AI power boom.

INSIDERS

DEEP DIVE

Latest Posts

AI EVENTS

spot_imgspot_img

Subcribe to newsletter

Html code here! Replace this with any non empty raw html code and that's it.
spot_imgspot_imgspot_img

Technology

EVENTS

Family Offices Pour $68B Into AI as Private Wealth Bets Earlier

TRENDSPOTTING
Family offices poured $68.3B into AI in Q3 2026 alone—discover how private wealth is betting earlier on pre-IPO AI and what concentration risk means for investors.

AI Data Center Natural Gas: The Six Hidden Risks Nobody Prices In

DEEP DIVE
AI data center natural gas hides six unpriced risks—emissions lock-in, ratepayer costs, and stranded assets. Discover who really pays for the AI power boom.

OpenAI Taps Greptile to Chase Bugs Past the Pull Request

IN ACTION
OpenAI taps Greptile's TREX, powered by GPT-6 Astra, to catch runtime bugs that pass CI and hit production. See how AI code review is shifting.

Cognichip’s $60M Bet: Physics-Informed AI in a Crowded Chip Design Race

FUTURE FRONTIERS
Cognichip raises $60M to scale physics-informed AI chip design with ACI®—delivering manufacturable silicon and slashing design timelines up to 10x.

When a Dog’s Cancer Went Viral: The Founder-Patient Era Arrives With a $4M Bet

IN ACTION
AI-designed dog cancer vaccine goes viral, raises $4M, then fails—learn why the founder-patient era is reshaping biotech despite zero FDA approvals.